| UUUSI UIPI | | | | | --- | --- | --- | --- | | 最终涨停14:25 | 磁材加工 | | | | 惠城环保 | | 131.27 | +7.41% -7.67% | | 创 300779 融 | | | | | 华新环保 | | 13.48 | +5.31% +10.66% | | 創 301265 融 | | | | | 领涨龙头2 | | | | | 九菱科技 | | 47.17 | +5.29% +0.32% | | 京A 920505 融 | | | | | 磁材加工 | | | | | 祥明智能 | | 28.95 | +5.08% +3.76% | | 创 301226 融 | | | | （文章来源：上海证券报） 有业内人士表示，通用许可证的应用将简化稀土永磁企业出口流程，加快交付速度，利于稀土永磁行业下游需求恢复。 今日尾盘，稀土永磁板块走高，宁波韵升（600366）涨停，金力永磁涨超10%，中科三环、九菱科技、中科磁业、广晟有色、银河磁体等跟涨。 12月5日，上证报记者从知情人士处获悉，金力永磁、中科三环、宁波韵升已获得通用出口许可证。 据新 ...

盘面上，截至发稿， 金力永磁涨超10%， 宁波韵升涨停， 中科三环大涨超9%，银河磁体、中科磁业 跟涨。 | 编辑 ｜ 钉钉 | | --- | 有业内人士表示，通用许可证的应用将简化稀土永磁企业出口流程，加快交付速度，利于稀土永磁行业 下游需求恢复。 据新华社此前报道，商务部新闻发言人何亚东4日表示，中国政府依法依规开展稀土相关物项出口管制 工作。只要是用于民用用途的、合规的出口申请，中国政府都及时予以了批准。同时，中国政府积极适 用通用许可等便利化措施，促进两用物项合规贸易，切实维护全球产供链安全稳定。 12月5日，据上海证券报报道，记者从知情人士处获悉，金力永磁、中科三环、宁波韵升已获得通用出 口许可证。 ...

| | | | | | 稀土永磁 1301.10 +3.40% 分时 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1301.10 | | | | | | | | | | 1292.54 | | | | | | | | | | 1283.97 | | | | | | | | | | 1275.41 | | | | | | | | | | 1266.84 | | | | | | | | | | 1258.28 | | | | | | | | | | 1249.72 | | | | | | | | | | 1241.15 | | | | | | | | | | 1232.59 | | | | | | | | | | 1224.02 | | | | | | | | | | 1215.46 | | | | | | | | | | 58.67万 | | | | | | | | | | 44.00万 | | | | | | | | | | 29.33万 | | | | | | | | | | 14.67万 | | | | | | | | ...

记者从知情人士处获悉，金力永磁、中科三环、宁波韵升已获得通用出口许可证。有业内人士表示，通 用许可证的应用将简化稀土永磁企业出口流程，加快交付速度，利于稀土永磁行业下游需求恢复。(上 海证券报) ...

2025年12月4日，公司收到中国证券登记结算有限责任公司出具的《过户登记确认书》，公司2025年员 工持股计划首批参加部分标的股票10,835,800股，已于2025年12月3日由公司回购专用证券账户非交易过 户至公司2025年员工持股计划证券账户，过户价格为7.03元/股。截至本公告发布之日，公司2025年员 工持股计划证券账户持有公司股票10,835,800股，占公司总股本的0.99%。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600366 证券简称：宁波韵升 编号：2025-074 宁波韵升股份有限公司 关于2025年员工持股计划首次授予部分完成股票非交易过户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 宁波韵升股份有限公司（以下简称"公司"）分别于2025年9月28日、2025年10月13日召开了公司第十一 届董事会第十一次会议和公司2025年第二次临时股东会，审议通过了《关于<宁波韵升股份有限公司 2025年员工持股计划（草案修订稿）>及其摘要的议案》及相关事项的议案,具体内容详见公司 ...

完成股票非交易过户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并 对其内容的真实性、准确性和完整性承担法律责任。 宁波韵升股份有限公司（以下简称"公司"）分别于2025年9月28日、2025年10月 13日召开了公司第十一届董事会第十一次会议和公司2025年第二次临时股东会，审议 通过了《关于<宁波韵升股份有限公司2025年员工持股计划（草案修订稿）>及其摘要 的议案》及相关事项的议案,具体内容详见公司于2025年9月29日、2025年10月14日在 上海证券报及上海证券交易所网站（www.sse.com.cn）披露的相关公告。 宁波韵升股份有限公司 关于 2025 年员工持股计划首次授予部分 2025年12月4日，公司收到中国证券登记结算有限责任公司出具的《过户登记确认 书》，公司2025年员工持股计划首批参加部分标的股票10,835,800股，已于2025年12 月3日由公司回购专用证券账户非交易过户至公司2025年员工持股计划证券账户，过户 价格为7.03元/股。截至本公告发布之日，公司2025年员工持股计划证券账户持有公司 股票10,835,800股，占公司 ...

Core Viewpoint - The trend of A-share companies planning to list in Hong Kong continues, with 18 companies disclosing their intentions to issue H-shares and list on the Hong Kong Stock Exchange in November [1] Group 1: Companies Planning to List - 18 A-share listed companies have announced plans to issue H-shares and list in Hong Kong from November 1 to November 29 [1] - Zhongji Xuchuang announced on November 10 its intention to issue H-shares and list on the Hong Kong Stock Exchange [1] Group 2: Specific Company Announcements - Runjian Co., Ltd. announced on November 25 its plan to issue H-shares and list in Hong Kong [2] - Ningbo Yunsheng authorized management on November 24 to initiate preparations for issuing H-shares and listing in Hong Kong [2] - Igor announced on November 24 its plan to issue H-shares and list in Hong Kong [2] - Miao Exhibition announced on November 24 its intention to issue H-shares and list in Hong Kong [2] - Zhuoyi Information announced on November 20 its plan to issue H-shares and list in Hong Kong [2] - Yuanjie Technology announced on November 19 its intention to issue H-shares and list in Hong Kong [2] - Dashang Co., Ltd. announced on November 18 its plan to issue H-shares and list in Hong Kong [2] - Sifang Jingchuang announced on November 14 its intention to issue H-shares and list on the main board of the Hong Kong Stock Exchange [2] - Zejing Pharmaceutical announced on November 14 its plan to issue H-shares and list in Hong Kong [2] - Juxin Technology announced on November 14 its intention to issue H-shares and list in Hong Kong [2] - Deye Co., Ltd. announced on November 13 its plan to issue H-shares and list in Hong Kong [2] - Tuosida announced on November 12 its intention to issue H-shares and list in Hong Kong [2] - Marumi Bio announced on November 12 its plan to issue H-shares and apply for listing in Hong Kong [2] - Transsion Holdings announced on November 12 its intention to issue H-shares and list in Hong Kong [2] - Anker Innovations announced on November 11 its plan to issue H-shares and list in Hong Kong [2] - Visual China announced on November 4 that it is planning to issue H-shares [2] - Juhe Materials announced on November 3 its plan to issue FF shares and list in Hong Kong [2]

Core Viewpoint - Ningbo Yunsheng Co., Ltd. is set to hold a Q3 2025 performance briefing on December 5, 2025, to provide insights into its operational results and financial status for the third quarter of 2025 [2][3]. Group 1: Meeting Details - The meeting will take place on December 5, 2025, from 13:00 to 14:00 [5]. - It will be held at the Shanghai Stock Exchange Roadshow Center, accessible via video live stream and online interaction [5]. - Investors can submit questions from November 28, 2025, to December 4, 2025, before 16:00 [6]. Group 2: Participation and Interaction - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center [4]. - The company will address commonly asked questions during the session [3][6]. - Key personnel attending include the Chairman, General Manager, and Financial Director [5].

证券代码：600366 证券简称：宁波韵升 公告编号：2025-073 宁波韵升股份有限公司 关于召开 2025 年三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频直播和网络互动 投资者可于 2025 年 11 月 28 日 （星期五） 至 12 月 4 日 （星 期四）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目 或通过公司邮箱 stock@ysweb.com 进行提问。公司将在说明会上对投 资者普遍关注的问题进行回答。 宁波韵升股份有限公司（以下简称"公司"）已于 2025 年 10 月 31 日发布公司 2025 年三季度报告，为便于广大投资者更全面深入地 了解公司 2025 年半年度经营成果、财务状况，公司计划于 2025 年 12 月 5 日 （星期五） 13:00-14:00 举行 2025 年三季度业绩说明会， 就投资者关心的问题进行交流。 一、 说明会类型 会议召开 ...

Core Viewpoint - Ningbo Yunsheng is planning to issue H-shares in Hong Kong to advance its international strategy, enhance brand image, and build a diversified capital platform [1][3]. Group 1: Financial Performance - For the first three quarters of 2025, Ningbo Yunsheng reported a net profit attributable to shareholders of 276 million yuan, a year-on-year increase of 299.04%, and a net profit excluding non-recurring items of 251 million yuan, up 302.29% [2][3]. - The company's total revenue for the same period reached 3.91 billion yuan, reflecting a year-on-year growth of 7.03% [2]. - As of the end of the first half of 2025, total assets increased to 10.302 billion yuan, a rise of 14.17% compared to the end of 2024, while equity attributable to shareholders grew to 6.121 billion yuan, up 3.84% [2]. Group 2: Business Operations - Ningbo Yunsheng specializes in the research, manufacturing, and sales of rare earth permanent magnet materials since 1995, with major production bases in Ningbo and Baotou [2]. - The company has an annual production capacity of 26,000 tons of high-performance neodymium-iron-boron magnets [2]. - The company has established strong partnerships in various sectors, including new energy vehicles and consumer electronics, supplying major brands and manufacturers [5][6]. Group 3: Research and Development - In the first three quarters of 2025, Ningbo Yunsheng's R&D expenses amounted to 214 million yuan, representing a year-on-year increase of 61.29%, with an R&D expense ratio of 5.47%, up 1.84 percentage points from the same period in 2024 [4][5]. - The company has developed a core technology system with proprietary breakthroughs in various areas, including rare earth product formulation and automation technology [5]. Group 4: Investment Activities - On November 24, 2025, Ningbo Yunsheng announced plans to invest 20 million yuan in the Lingzhi New Venture Capital Partnership, focusing on innovative companies in the embodied intelligence industry [1][6]. - The investment aims to leverage professional investment resources and experience to identify quality targets and reduce investment risks, aligning with the company's strategic development needs [7].